Filter News

Invivodata Is First To Deploy New Tungsten E2 Handheld From palmOne In Clinical Trials

Published: Apr 13, 2005

MILPITAS, Calif., April 13 /PRNewswire-FirstCall/ -- palmOne, Inc. today announced that invivodata(R) inc., an industry leader in electronic patient reported outcome (PRO) solutions for clinical research, has plans to deploy between 5,000 and 7,000 Tungsten(TM) E2 handhelds from palmOne for use in worldwide clinical trials during the next 90 days. As the demand for invivodata's unique electronic diary system, DiaryPRO(TM) continues to grow, the number of deployed devices could easily be four times that amount by the end of 2005.

[NOTE: See today's related release from palmOne, "palmOne Introduces Sleek, Stylish Tungsten E2 Handheld."]

By combining behavioral science and clinical expertise with palmOne's proven handheld technology, invivodata's electronic diary system increases patient compliance with reporting requirements to more than 90 percent, up from less than 20 percent with conventional paper-based diaries(1). This dramatic increase in compliance delivers higher-integrity PRO data that trial sponsors can rely upon as they evaluate the effectiveness of new treatments. In fact, invivodata's electronic diary has successfully delivered key data for multiple new drug approvals granted by the Food and Drug Administration (FDA).

"By deploying our scientific expertise on palmOne's newest handheld product, we will continue to deliver unique solutions that streamline the clinical drug development process and put patients back at the center of research where they belong," said Doug Engfer, president and chief executive officer of invivodata. "We look forward to standardizing on the Tungsten E2 as our device of choice and leveraging its flexibility and ease of use in clinical trials throughout the world."

The Tungsten E2 builds on the popularity of the Tungsten E handheld, which has sold nearly 2 million units worldwide. The Tungsten E2's non-volatile memory and Bluetooth(R) technology are key enablers for clinical trial use. While non-volatile memory keeps trial data secure, Bluetooth technology enables integration with physiological devices, such as peak flow meters, a standard tool used in respiratory trials.

"With the ever-increasing importance being placed on high-quality patient- reported data, we answered our customers' demand by delivering a handheld computer with non-volatile, flash memory to keep all information on the product safe, even if there's no time to recharge," said Tara Griffin, vice president, Americas Sales, for palmOne. "It's rewarding to see how invivodata and its pharmaceutical, biotech and medical device company clients will benefit from all of the Tungsten E2's new features."

About invivodata inc.

invivodata ( http://www.invivodata.com/ ) combines behavioral science, information technology and clinical expertise to capture clinical trial data of the highest integrity directly from patients. invivodata's electronic patient reported outcomes (PRO) system delivers high-quality patient self- reported data by driving patient compliance with the protocol and eliminating recall biases that plague self-report studies. The invivodata solution, which includes DiaryPRO(TM) for real-time PRO data collection and SitePRO(TM) for site-based PRO data collection, provides access to study data, giving researchers and sponsors visibility into study progress and improving trial efficiencies. invivodata's solution has been used in more than 100 trials involving over 35,000 patients. It has also collected nearly 50 million patient-initiated records, and is the only eDiary system that has delivered primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA.

About palmOne, Inc.

palmOne, Inc. -- a leader in handheld computing and communications solutions -- strives to put the power of computing in people's hands so they can access and share their most important information. The company's products include Treo(TM) smartphones, Zire(TM) and Tungsten(TM) handhelds, and software and accessories.

palmOne products are sold through select Internet, retail, reseller and wireless operator channels throughout the world, and at palmOne Retail Stores and palmOne online stores ( http://www.palmone.com/stores ).

More information about palmOne, Inc. is available at http://www.palmone.com/ .

(1) British Medical Journal, Volume 324, May 18, 2002

NOTE: palmOne, Tungsten, Zire and Treo are among the trademarks or registered trademarks owned by or licensed to palmOne, Inc. or its subsidiaries. The Bluetooth word mark and logos are owned by the Bluetooth SIG, Inc. and any use of such marks by palmOne, Inc. is under license. All other brand and product names are or may be trademarks of, and are used to identify products or services of, their respective owners.

palmOne, Inc.

CONTACT: Erin Freeley of A&R Partners, +1-650-762-2863, orefreeley@arpartners.com, for palmOne, Inc.

Back to news